Potential use of two aryl sulfotransferase cell-surface display systems to detoxify the endocrine disruptor bisphenol A. Nanudorn P, Thiengmag S, Whangsuk W, Mongkolsuk S, Loprasert S. Biochem Biophys Res Commun. 2020 Aug 6;528(4):691-697. doi: 10.1016/j.bbrc.2020.05.129. Epub 2020 Jun 6. PMID: 32513533

28 Dec 2020
0
0

Potential use of two aryl sulfotransferase cell-surface display systems to detoxify the endocrine disruptor bisphenol A.
Nanudorn P, Thiengmag S, Whangsuk W, Mongkolsuk S, Loprasert S.
Biochem Biophys Res Commun. 2020 Aug 6;528(4):691-697. doi: 10.1016/j.bbrc.2020.05.129. Epub 2020 Jun 6.
PMID: 32513533

Tags

Share this

Related Posts

Determination of perfluorooctane sulphonate and perfluorooctanoic acid in seafood and water from Map Ta Phut Industrial Estate area, Thailand Lertassavakorn T, Pholphana N, Rangkadilok N, Suriyo T, Satayavivad J Food Addit Contam Part A. 2021.
02 Jun 2021
0

Determination of perfluorooctane sulphonate and perfluorooctanoic acid in seafood and water from Map Ta Phut Industrial Estate area, Thailand Lertassavakorn T, Pholphana N, Rangkadilok N, Suriyo T, Satayavivad J Food Addit Contam Part A. 2021.

Determination of perfluorooctane sulphonate and perfluorooctanoic acid in seafood and water from Map Ta Phut Industrial Estate area, Thailand. Lertassavakorn T, Pholphana N, Rangkadilok N, Suriyo T, Satayavivad J. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2021 Jun 2:1-16.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More